Article
Explore the alterations of downstream molecular pathways caused by ARID1A mutation/knockout in human endometrial cancer cells.
Journal of cancer research and clinical oncology - 1 Dec 2023
Xing Baoling, Zhang Xiaoying, Gu Xia, Xiang Lintao, Wang Cuiping, Jin Yueling
Abstract excerpt
PURPOSE: As one of the most common gynecologic malignancies, endometrial cancer (EC) is driven by multiple genetic alterations that may be targeted for treatments. AT-rich interaction domain 1A (ARID1A) gene mutations were reported as early events in endometrial carcinogenesis. METHODS: To explore the alterations of downstream molecular pathways caused by ARID1A mutations and the associated therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
